Breast Neoplasms

Showing NaN - NaN of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Triple Negative Breast Cancer
  • +6 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
  • +1 more
Mar 8, 2023

Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

Completed
  • Breast Neoplasms
  • KU-0059436 (AZD2281) (PARP inhibitor)
  • West Hollywood, California
  • +16 more
Jan 24, 2023

Breast Cancer, Breast Tumors, Breast Carcinoma Trial in Boston (Breast Cancer Survivor Education Program)

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Breast Cancer Survivor Education Program
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 17, 2023

Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)

Active, not recruiting
  • Breast Neoplasms
  • Fayetteville, Arkansas
  • +141 more
Nov 15, 2022

Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)

Not yet recruiting
  • Breast Neoplasms
  • Neoplasm Metastasis
  • CodaLytic
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Breast Tumors Trial in New Haven, Boston (Dietary/Physical Activity intervention, Usual Care)

Active, not recruiting
  • Breast Neoplasms
  • Dietary/Physical Activity intervention
  • Usual Care
  • New Haven, Connecticut
  • +1 more
Oct 4, 2022

Ovarian Tumors, Breast Tumors Trial in Worldwide (Niraparib)

Active, not recruiting
  • Ovarian Neoplasms
  • Breast Neoplasms
  • Tucson, Arizona
  • +22 more
Jul 20, 2022

Liposarcoma, CRC, Prostate Cancer Trial in United States (PF-07220060, Letrozole, Fulvestrant)

Recruiting
  • Liposarcoma
  • +5 more
  • New Haven, Connecticut
  • +8 more
Jan 20, 2022

Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)

Completed
  • Breast Neoplasms
  • Fullerton, California
  • +43 more
Feb 18, 2021

Breast Tumors Trial in United States (Trastuzumab, pertuzumab, lapatinib)

Completed
  • Breast Neoplasms
  • Birmingham, Alabama
  • +4 more
Sep 3, 2020

Breast Tumors, Tumor Metastasis Trial in Puerto Rico, United States (ABI-007 (Abraxane), bevacizumab)

Terminated
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Birmingham, Alabama
  • +39 more
Nov 7, 2019

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

Breast Tumors, Pancreatic Tumors Trial in United States (nab-Paclitaxel, Nivolumab, Gemcitabine)

Completed
  • Breast Neoplasms
  • Pancreatic Neoplasms
  • Sacramento, California
  • +14 more
May 29, 2019

Breast Cancer, Breast Tumors, Breast Tumors Trial in Belgium, France, United States (AMG 386 30 mg/kg, Paclitaxel and

Completed
  • Breast Cancer
  • +9 more
  • AMG 386 30 mg/kg, Paclitaxel and Trastuzumab
  • +3 more
  • Tucson, Arizona
  • +22 more
Apr 2, 2019

Pancreatic Tumors, Ovarian Tumors, Breast Tumors Trial in United States (BTP-114)

Unknown status
  • Pancreatic Neoplasms
  • +3 more
  • Sarasota, Florida
  • +7 more
Jan 11, 2019

Breast Tumors Trial in United States (neratinib)

Completed
  • Breast Neoplasms
  • Tampa, Florida
  • +4 more
Aug 17, 2018

Breast Tumors, Tumors Trial in Worldwide (neratinib)

Completed
  • Breast Neoplasms
  • Neoplasms
  • Aurora, Colorado
  • +32 more
Aug 10, 2018

Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent

Completed
  • Breast Neoplasms
    • Boston, Massachusetts
    • +1 more
    Mar 30, 2017

    Breast Tumors Trial in Boston (Visualization relaxation, Visual Milieu Enhancement (Fine art photograph))

    Terminated
    • Breast Neoplasms
    • Visualization relaxation
    • Visual Milieu Enhancement (Fine art photograph)
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Mar 22, 2017

    Breast Cancer, Breast Tumors Trial in Spain, United States (XL147 (SAR245408), trastuzumab, paclitaxel)

    Completed
    • Breast Cancer
    • Breast Neoplasms
    • XL147 (SAR245408)
    • +2 more
    • Los Angeles, California
    • +8 more
    May 9, 2016

    Breast Tumors Trial in Worldwide (CP-751,871, exemestane, Fulvestrant)

    Terminated
    • Breast Neoplasms
    • La Jolla, California
    • +62 more
    Oct 6, 2015